Aurinia Pharmaceuticals (NASDAQ: AUPH)

Are These Analysts Right About Aurinia Pharmaceuticals (NASDAQ: AUPH)?

  Aurinia Pharmaceuticals (NASDAQ: AUPH) just received some analyst ratings, and it seems like some of them are bullish on the name. Aurinia Pharmaceuticals is a late-stage biopharma company that provides products...